secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001477932-26-002373
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx board approves 1-for-20 reverse stock split effective April 28, 2026
-------------------------------------------------------------------------------

- Reverse stock split ratio set at 1-for-20, effective 12:01 a.m. ET on April 28, 2026.
- No fractional shares; holders receive one whole share for any fractional interest.
- Proportional adjustments to outstanding warrants, options, awards, and convertible notes.
- Split follows shareholder approval at March 31, 2026 special meeting; tied to Lind Global financings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002373/0001477932-26-002373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002373/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer